Owkin Advances Biological AI Super Intelligence with NVIDIA
Collaboration Leverages NVIDIA’s Open Models, AI Infrastructure and Expertise to Build Next-Generation Biological Reasoning Models for Drug Development Owkin, an AI company on a mission...
Tag : Owkin
Owkin Unveils Europe’s First Pan-European Agentic Infrastructure
At today’s Franco-German Summit on Digital Sovereignty in Berlin, Owkin, together with leading academic partners Gustave Roussy (France) and Charité Comprehensive Cancer Center (Germany), announced...
Owkin doses first patient in AI-optimized trial of OKN4395.
Owkin, the first end-to-end AI-biotech that uses agentic AI to revolutionize drug discovery, development, and diagnostics, today announced that the first patient has been dosed...